Gregg A. Robbins-Welty, MD, MS

Dr Robbins-Welty is chief resident of the combined Internal Medicine & Psychiatry residency program in the departments of medicine and psychiatry at Duke University Medical Center in Durham, North Carolina.

Articles by Gregg A. Robbins-Welty, MD, MS

gastrointestinal

Serotonin Reuptake Inhibitor and Bleeding Risk, Part 2: Gastrointestinal (GI) Bleeding, Malignancy, Pregnancy, and Surgical Considerations

ByGregg A. Robbins-Welty, MD, MS,Andrew N. Tuck, MD,Dale Marchant, FRANZCP,Andrew Gleason, FRANZCP,Richard Garrett Key, MD,Barbara Lubrano Di Ciccone, MD,Deepti A. Chopra, MBBS,Mona Mojtahedzadeh, MD,Fíona Fonseca, MD,Hermioni Lokko Amonoo, MD,Andrea DeSimone, DO,Daniel C. McFarland, DO

In this CME article, review literature on SRI-related bleeding complications in patients with GI bleeding, malignancy, perioperative settings, pregnancy, and hormonal therapy.

bleeding

Bleeding Risk With SSRIs, Part 1: Cardiovascular and Cerebrovascular Considerations

ByGregg A. Robbins-Welty, MD, MS,Andrew N. Tuck, MD,Dale Marchant, FRANZCP,Andrew Gleason, FRANZCP,Richard Garrett Key, MD,Barbara Lubrano Di Ciccone, MD,Deepti A. Chopra, MBBS,Mona Mojtahedzadeh, MD,Fíona Fonseca, MD,Hermioni Lokko Amonoo, MD,Andrea DeSimone, DO,Daniel C. McFarland, DO

In this CME article, get a better understanding of bleeding risk associated with use of serotonin reuptake inhibitors (SRIs) and review research-informed literature on related bleeding complications in patients with cardiovascular and cerebrovascular disease.

Latest Updated Articles



    Contact Info

    259 Prospect Plains Rd, Bldg H
    Monroe, NJ 08831

    609-716-7777

    Brand Logo

    © 2025 MJH Life Sciences®

    All rights reserved.

    Home
    About Us
    News
    Contact Us